260 related articles for article (PubMed ID: 21615491)
21. RBM5/H37 tumor suppressor, located at the lung cancer hot spot 3p21.3, alters expression of genes involved in metastasis.
Oh JJ; Taschereau EO; Koegel AK; Ginther CL; Rotow JK; Isfahani KZ; Slamon DJ
Lung Cancer; 2010 Dec; 70(3):253-62. PubMed ID: 20338664
[TBL] [Abstract][Full Text] [Related]
22. Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis.
Gao W; Yu Y; Cao H; Shen H; Li X; Pan S; Shu Y
Biomed Pharmacother; 2010 Jul; 64(6):399-408. PubMed ID: 20363096
[TBL] [Abstract][Full Text] [Related]
23. An estrogen receptor alpha suppressor, microRNA-22, is downregulated in estrogen receptor alpha-positive human breast cancer cell lines and clinical samples.
Xiong J; Yu D; Wei N; Fu H; Cai T; Huang Y; Wu C; Zheng X; Du Q; Lin D; Liang Z
FEBS J; 2010 Apr; 277(7):1684-94. PubMed ID: 20180843
[TBL] [Abstract][Full Text] [Related]
24. Anticancer activity of litchi fruit pericarp extract against human breast cancer in vitro and in vivo.
Wang X; Yuan S; Wang J; Lin P; Liu G; Lu Y; Zhang J; Wang W; Wei Y
Toxicol Appl Pharmacol; 2006 Sep; 215(2):168-78. PubMed ID: 16563451
[TBL] [Abstract][Full Text] [Related]
25. Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22.
Patel JB; Appaiah HN; Burnett RM; Bhat-Nakshatri P; Wang G; Mehta R; Badve S; Thomson MJ; Hammond S; Steeg P; Liu Y; Nakshatri H
Oncogene; 2011 Mar; 30(11):1290-301. PubMed ID: 21057539
[TBL] [Abstract][Full Text] [Related]
26. Human melatonin MT1 receptor induction by valproic acid and its effects in combination with melatonin on MCF-7 breast cancer cell proliferation.
Jawed S; Kim B; Ottenhof T; Brown GM; Werstiuk ES; Niles LP
Eur J Pharmacol; 2007 Mar; 560(1):17-22. PubMed ID: 17303109
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA expression and its implications for the diagnosis and therapeutic strategies of breast cancer.
Shi M; Guo N
Cancer Treat Rev; 2009 Jun; 35(4):328-34. PubMed ID: 19171434
[TBL] [Abstract][Full Text] [Related]
28. MicroRNAs 143 and 145 are possible common onco-microRNAs in human cancers.
Akao Y; Nakagawa Y; Naoe T
Oncol Rep; 2006 Oct; 16(4):845-50. PubMed ID: 16969504
[TBL] [Abstract][Full Text] [Related]
29. Identification of altered MicroRNA expression patterns in synovial sarcoma.
Hisaoka M; Matsuyama A; Nagao Y; Luan L; Kuroda T; Akiyama H; Kondo S; Hashimoto H
Genes Chromosomes Cancer; 2011 Mar; 50(3):137-45. PubMed ID: 21213367
[TBL] [Abstract][Full Text] [Related]
30. MicroRNAs as prognostic indicators and therapeutic targets: potential effect on breast cancer management.
Lowery AJ; Miller N; McNeill RE; Kerin MJ
Clin Cancer Res; 2008 Jan; 14(2):360-5. PubMed ID: 18223209
[TBL] [Abstract][Full Text] [Related]
31. Alteration of the MT1 melatonin receptor gene and its expression in primary human breast tumors and breast cancer cell lines.
Lai L; Yuan L; Cheng Q; Dong C; Mao L; Hill SM
Breast Cancer Res Treat; 2009 Nov; 118(2):293-305. PubMed ID: 18979234
[TBL] [Abstract][Full Text] [Related]
32. Transcriptional profiling of breast cancer cells exposed to soy phytoestrogens after BRCA1 knockdown with a whole human genome microarray approach.
Satih S; Chalabi N; Rabiau N; Bignon YJ; Bernard-Gallon DJ
Nutr Cancer; 2010; 62(5):659-67. PubMed ID: 20574927
[TBL] [Abstract][Full Text] [Related]
33. Characterization of microRNA-125b expression in MCF7 breast cancer cells by ATR-FTIR spectroscopy.
Ozek NS; Tuna S; Erson-Bensan AE; Severcan F
Analyst; 2010 Dec; 135(12):3094-102. PubMed ID: 20978686
[TBL] [Abstract][Full Text] [Related]
34. Characterization of microRNA expression levels and their biological correlates in human cancer cell lines.
Gaur A; Jewell DA; Liang Y; Ridzon D; Moore JH; Chen C; Ambros VR; Israel MA
Cancer Res; 2007 Mar; 67(6):2456-68. PubMed ID: 17363563
[TBL] [Abstract][Full Text] [Related]
35. miR-218 on the genomic loss region of chromosome 4p15.31 functions as a tumor suppressor in bladder cancer.
Tatarano S; Chiyomaru T; Kawakami K; Enokida H; Yoshino H; Hidaka H; Yamasaki T; Kawahara K; Nishiyama K; Seki N; Nakagawa M
Int J Oncol; 2011 Jul; 39(1):13-21. PubMed ID: 21519788
[TBL] [Abstract][Full Text] [Related]
36. The extract of huanglian, a medicinal herb, induces cell growth arrest and apoptosis by upregulation of interferon-beta and TNF-alpha in human breast cancer cells.
Kang JX; Liu J; Wang J; He C; Li FP
Carcinogenesis; 2005 Nov; 26(11):1934-9. PubMed ID: 15958519
[TBL] [Abstract][Full Text] [Related]
37. Differential expression of microRNA (miRNA) in chordoma reveals a role for miRNA-1 in Met expression.
Duan Z; Choy E; Nielsen GP; Rosenberg A; Iafrate J; Yang C; Schwab J; Mankin H; Xavier R; Hornicek FJ
J Orthop Res; 2010 Jun; 28(6):746-52. PubMed ID: 20041488
[TBL] [Abstract][Full Text] [Related]
38. Prioritizing breast cancer subtype related miRNAs using miRNA-mRNA dysregulated relationships extracted from their dual expression profiling.
Hua L; Zhou P; Li L; Liu H; Yang Z
J Theor Biol; 2013 Aug; 331():1-11. PubMed ID: 23619378
[TBL] [Abstract][Full Text] [Related]
39. Inferring coregulation of transcription factors and microRNAs in breast cancer.
Wu JH; Sun YJ; Hsieh PH; Shieh GS
Gene; 2013 Apr; 518(1):139-44. PubMed ID: 23246694
[TBL] [Abstract][Full Text] [Related]
40. microrna expression signature of gastric cancer cells relative to normal gastric mucosa.
Yu BQ; Su LP; Li JF; Cai Q; Yan M; Chen XH; Yu YY; Gu QL; Zhu ZG; Liu BY
Mol Med Rep; 2012 Oct; 6(4):821-6. PubMed ID: 22842726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
